Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Heparin Inhibits SARS-CoV-2 Replication in Human Nasal Epithelial Cells

24 Nov 2022

Abstract excerpt

SARS-CoV-2 is the causative agent of the COVID-19 pandemic. Vaccination, supported by social and public health measures, has proven efficacious for reducing disease severity and virus spread. However, the emergence of highly transmissible viral variants that escape prior immunity highlights the need for additional mitigation approaches. Heparin binds the SARS-CoV-2 spike protein and can inhibit virus entry and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Influenza Virus Research Studies
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36560624
DOI: 10.3390/v14122620

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Heparin Inhibits SARS-CoV-2 Replication in Human Nasal Epithelial CellsPMID 36560624Read ↗

Infection and transmission of SARS-CoV-2 depends on heparan sulfate proteoglycansSemantic proximity Read ↗

Cell Surface SARS-CoV-2 Nucleocapsid Protein Modulates Innate and Adaptive ImmunitySemantic proximity Read ↗

TaffiX® nasal powder spray forms an effective barrier against infectious new variants of SARS-CoV-2 (Alpha, Beta and Delta)Semantic proximity Read ↗

Cell Surface SARS-CoV-2 Nucleocapsid Protein Modulates Innate and Adaptive ImmunitySemantic proximity Read ↗

Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin DerivativesSemantic proximity Read ↗

Host and viral determinants for efficient SARS-CoV-2 infection of the human lungSemantic proximity Read ↗

Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissueSemantic proximity Read ↗

Transfer of SARS-CoV-2 nucleocapsid protein to uninfected epithelial cells induces antibody-mediated complement depositionSemantic proximity Read ↗

Human Nasal and Lung Tissues Infected Ex Vivo with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory TractSemantic proximity Read ↗

Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profilesSemantic proximity Read ↗

Glycosaminoglycans induce conformational change in the SARS-CoV-2 Spike S1 Receptor Binding DomainSemantic proximity Read ↗

A randomized, placebo-controlled trial of a nasal spray solution containing broadly potent neutralizing antibodies against SARS-CoV-2 variants in healthy volunteersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.